LEGISLATIVE AND REGULATORY UPDATE
Week in Brief
Senate Appropriations Committee Majority Releases Continuing Resolution to Fund Federal Government, Several Additional Priorities.
WHITE HOUSE UPDATE
September 19
White House Announces Prescription Opioid and Heroin Epidemic Awareness Week.
LEGISLATIVE UPDATE
September 20
Senate HELP Committee Holds Hearing on Laboratory Developed Tests.
September 21
House Energy & Commerce Committee Approves Several Public Health Measures.
House Oversight & Government Reform Committee Reviews the Rising Price of EpiPens in Hearing.
Senate Indian Affairs Committee Passes Bill to Reform the Indian Health Service.
Senate Appropriations Subcommittee Conducts Hearing on FDA Role in Generic Drug Marketplace.
REGULATORY UPDATE
Department of Health and Human Services
September 19
CDC Declares Wynwood, Florida Safe for Travelers After Being Under Zika Travel Advisory.
September 20
CMS Releases Evaluation Report on Bundled Payments for Care Improvement.
September 21
HHS Issues Final Rule in Efforts to Increase Public Access to Clinical Trial Information.
September 22
HHS Secretary Approves Renewal of Charter for The Advisory Committee on Organ Transplantation.
CMS Announces That Medicare Advantage Premiums Will Decrease by 4% in 2017.
UPCOMING EVENTS
Congressional Hearings/Markups
- House Ways and Means Committee
Hearing on Healthcare Fraud Investigations
- September 28 | 10 a.m.
- Longworth House Office Building, Room 1100
- September 28 | 10 a.m.
Department of Health and Human Services
- Meeting of the National Advisory Council on the National Health Service Corps
- September 28| 12:00 p.m. to 3:30 p.m.
- 5600 Fishers Lane, Rockville, Maryland 20857
- September 28| 12:00 p.m. to 3:30 p.m.
For more information about this issue of Power Play: Washington Week in Review or more legislative and regulatory updates, contact the Powers Pyles Sutter & Verville Government Relations and Public Policy group at (202) 466-6550.